764 related articles for article (PubMed ID: 18250181)
21. Budesonide added to formoterol contributes to improved exercise tolerance in patients with COPD.
Worth H; Förster K; Eriksson G; Nihlén U; Peterson S; Magnussen H
Respir Med; 2010 Oct; 104(10):1450-9. PubMed ID: 20692140
[TBL] [Abstract][Full Text] [Related]
22. Effect of endurance training on expiratory flow limitation and dynamic hyperinflation in patients with stable chronic obstructive pulmonary disease.
Chen R; Chen R; Chen X; Chen L
Intern Med J; 2014 Aug; 44(8):791-800. PubMed ID: 24860934
[TBL] [Abstract][Full Text] [Related]
23. Exercise duration rather than peak oxygen uptake better correlates with Fev1 and inspiratory capacity in chronic obstructive pulmonary disease.
Metin G; Oztürk L; Duman ES; Demir T
Arch Med Res; 2007 Nov; 38(8):876-81. PubMed ID: 17923270
[TBL] [Abstract][Full Text] [Related]
24. Bronchodilators accelerate the dynamics of muscle O2 delivery and utilisation during exercise in COPD.
Berton DC; Barbosa PB; Takara LS; Chiappa GR; Siqueira AC; Bravo DM; Ferreira LF; Neder JA
Thorax; 2010 Jul; 65(7):588-93. PubMed ID: 20627914
[TBL] [Abstract][Full Text] [Related]
25. [Effect of dynamic hyperinflation on exertional dyspnea, exercise performance and quality of life in COPD].
Ozgur ES; Atis S; Kanik A
Tuberk Toraks; 2008; 56(3):296-303. PubMed ID: 18932031
[TBL] [Abstract][Full Text] [Related]
26. Inhaled beta-agonists improve lung function but not maximal exercise capacity in cystic fibrosis.
Dodd JD; Barry SC; Daly LE; Gallagher CG
J Cyst Fibros; 2005 May; 4(2):101-5. PubMed ID: 15978535
[TBL] [Abstract][Full Text] [Related]
27. The connection between chronic obstructive pulmonary disease symptoms and hyperinflation and its impact on exercise and function.
Cooper CB
Am J Med; 2006 Oct; 119(10 Suppl 1):21-31. PubMed ID: 16996896
[TBL] [Abstract][Full Text] [Related]
28. Polyunsaturated fatty acids improve exercise capacity in chronic obstructive pulmonary disease.
Broekhuizen R; Wouters EF; Creutzberg EC; Weling-Scheepers CA; Schols AM
Thorax; 2005 May; 60(5):376-82. PubMed ID: 15860712
[TBL] [Abstract][Full Text] [Related]
29. Aclidinium improves exercise endurance, dyspnea, lung hyperinflation, and physical activity in patients with COPD: a randomized, placebo-controlled, crossover trial.
Beeh KM; Watz H; Puente-Maestu L; de Teresa L; Jarreta D; Caracta C; Garcia Gil E; Magnussen H
BMC Pulm Med; 2014 Dec; 14():209. PubMed ID: 25539654
[TBL] [Abstract][Full Text] [Related]
30. Effect of obesity on respiratory mechanics during rest and exercise in COPD.
Ora J; Laveneziana P; Wadell K; Preston M; Webb KA; O'Donnell DE
J Appl Physiol (1985); 2011 Jul; 111(1):10-9. PubMed ID: 21350021
[TBL] [Abstract][Full Text] [Related]
31. Breathing pattern and chest wall volumes during exercise in patients with cystic fibrosis, pulmonary fibrosis and COPD before and after lung transplantation.
Wilkens H; Weingard B; Lo Mauro A; Schena E; Pedotti A; Sybrecht GW; Aliverti A
Thorax; 2010 Sep; 65(9):808-14. PubMed ID: 20805177
[TBL] [Abstract][Full Text] [Related]
32. Assessing the impact of pulmonary rehabilitation on functional status in COPD.
Laviolette L; Bourbeau J; Bernard S; Lacasse Y; Pepin V; Breton MJ; Baltzan M; Rouleau M; Maltais F
Thorax; 2008 Feb; 63(2):115-21. PubMed ID: 17901158
[TBL] [Abstract][Full Text] [Related]
33. Seven-year time course of lung function, symptoms, health-related quality of life, and exercise tolerance in COPD patients undergoing pulmonary rehabilitation programs.
Foglio K; Bianchi L; Bruletti G; Porta R; Vitacca M; Balbi B; Ambrosino N
Respir Med; 2007 Sep; 101(9):1961-70. PubMed ID: 17531455
[TBL] [Abstract][Full Text] [Related]
34. [Evaluation of dynamic hyperinflation parameters and exercise capacity at maximal exercise in patients with COPD].
Ulubay G; Görek A; Savaş S; Oner Eyüboğlu F
Tuberk Toraks; 2005; 53(4):340-6. PubMed ID: 16456732
[TBL] [Abstract][Full Text] [Related]
35. [Effect of ipratropium bromide on lung dynamic hyperinflation in patients with chronic obstructive lung disease].
Jorquera J; Díaz O; Lisboa C
Rev Med Chil; 2003 Jun; 131(6):605-12. PubMed ID: 12942587
[TBL] [Abstract][Full Text] [Related]
36. Effect of heliox on lung dynamic hyperinflation, dyspnea, and exercise endurance capacity in COPD patients.
Palange P; Valli G; Onorati P; Antonucci R; Paoletti P; Rosato A; Manfredi F; Serra P
J Appl Physiol (1985); 2004 Nov; 97(5):1637-42. PubMed ID: 15234959
[TBL] [Abstract][Full Text] [Related]
37. Superiority of "triple" therapy with salmeterol/fluticasone propionate and tiotropium bromide versus individual components in moderate to severe COPD.
Singh D; Brooks J; Hagan G; Cahn A; O'Connor BJ
Thorax; 2008 Jul; 63(7):592-8. PubMed ID: 18245142
[TBL] [Abstract][Full Text] [Related]
38. Reliability of ventilatory parameters during cycle ergometry in multicentre trials in COPD.
O'Donnell DE; Travers J; Webb KA; He Z; Lam YM; Hamilton A; Kesten S; Maltais F; Magnussen H
Eur Respir J; 2009 Oct; 34(4):866-74. PubMed ID: 19282342
[TBL] [Abstract][Full Text] [Related]
39. Effect of biventricular pacing on ventilatory and perceptual responses to exercise in patients with stable chronic heart failure.
Laveneziana P; O'Donnell DE; Ofir D; Agostoni P; Padeletti L; Ricciardi G; Palange P; Duranti R; Scano G
J Appl Physiol (1985); 2009 May; 106(5):1574-83. PubMed ID: 19246658
[TBL] [Abstract][Full Text] [Related]
40. Inhaled corticosteroids as additional treatment in alpha-1-antitrypsin-deficiency-related COPD.
Corda L; Bertella E; La Piana GE; Boni E; Redolfi S; Tantucci C
Respiration; 2008; 76(1):61-8. PubMed ID: 18319586
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
